Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Down 13.4% in October

Check-Cap Ltd. (NASDAQ:CHEK) saw a significant decline in short interest in October. As of October 31st, there was short interest totalling 14,200 shares, a decline of 13.4% from the October 15th total of 16,400 shares. Based on an average daily volume of 14,900 shares, the days-to-cover ratio is currently 1.0 days. Currently, 0.3% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on Check-Cap in a research note on Sunday. They issued a “sell” rating on the stock.

Check-Cap Trading Up 3.3 %

Shares of CHEK traded up $0.03 during mid-day trading on Monday, reaching $0.80. The company’s stock had a trading volume of 14,965 shares, compared to its average volume of 84,045. Check-Cap has a 1-year low of $0.76 and a 1-year high of $3.62. The stock has a market cap of $4.68 million, a P/E ratio of -0.26 and a beta of 0.39. The business has a 50-day simple moving average of $1.37 and a two-hundred day simple moving average of $1.82.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.